254 related articles for article (PubMed ID: 23266827)
1. Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload.
Manso AM; Li R; Monkley SJ; Cruz NM; Ong S; Lao DH; Koshman YE; Gu Y; Peterson KL; Chen J; Abel ED; Samarel AM; Critchley DR; Ross RS
J Biol Chem; 2013 Feb; 288(6):4252-64. PubMed ID: 23266827
[TBL] [Abstract][Full Text] [Related]
2. Loss of talin in cardiac fibroblasts results in augmented ventricular cardiomyocyte hypertrophy in response to pressure overload.
Noll NA; Riley LA; Moore CS; Zhong L; Bersi MR; West JD; Zent R; Merryman WD
Am J Physiol Heart Circ Physiol; 2022 May; 322(5):H857-H866. PubMed ID: 35333120
[TBL] [Abstract][Full Text] [Related]
3. Loss of mouse cardiomyocyte talin-1 and talin-2 leads to β-1 integrin reduction, costameric instability, and dilated cardiomyopathy.
Manso AM; Okada H; Sakamoto FM; Moreno E; Monkley SJ; Li R; Critchley DR; Ross RS
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6250-E6259. PubMed ID: 28698364
[TBL] [Abstract][Full Text] [Related]
4. Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation.
Chung E; Yeung F; Leinwand LA
J Appl Physiol (1985); 2012 May; 112(9):1564-75. PubMed ID: 22345431
[TBL] [Abstract][Full Text] [Related]
5. Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.
Ulm S; Liu W; Zi M; Tsui H; Chowdhury SK; Endo S; Satoh Y; Prehar S; Wang R; Cartwright EJ; Wang X
J Mol Cell Cardiol; 2014 Jul; 72(100):104-16. PubMed ID: 24631771
[TBL] [Abstract][Full Text] [Related]
6. CD38 promotes angiotensin II-induced cardiac hypertrophy.
Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
[TBL] [Abstract][Full Text] [Related]
7. DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility.
Maillet M; Purcell NH; Sargent MA; York AJ; Bueno OF; Molkentin JD
J Biol Chem; 2008 Nov; 283(45):31246-55. PubMed ID: 18753132
[TBL] [Abstract][Full Text] [Related]
8. IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.
Sbroggiò M; Carnevale D; Bertero A; Cifelli G; De Blasio E; Mascio G; Hirsch E; Bahou WF; Turco E; Silengo L; Brancaccio M; Lembo G; Tarone G
Cardiovasc Res; 2011 Aug; 91(3):456-64. PubMed ID: 21493702
[TBL] [Abstract][Full Text] [Related]
9. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
10. Talin1 is required for cardiac Z-disk stabilization and endothelial integrity in zebrafish.
Wu Q; Zhang J; Koh W; Yu Q; Zhu X; Amsterdam A; Davis GE; Arnaout MA; Xiong JW
FASEB J; 2015 Dec; 29(12):4989-5005. PubMed ID: 26310270
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
[TBL] [Abstract][Full Text] [Related]
12. RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis.
Lauriol J; Keith K; Jaffré F; Couvillon A; Saci A; Goonasekera SA; McCarthy JR; Kessinger CW; Wang J; Ke Q; Kang PM; Molkentin JD; Carpenter C; Kontaridis MI
Sci Signal; 2014 Oct; 7(348):ra100. PubMed ID: 25336613
[TBL] [Abstract][Full Text] [Related]
13. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Streicher JM; Ren S; Herschman H; Wang Y
Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
[TBL] [Abstract][Full Text] [Related]
14. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload.
De Acetis M; Notte A; Accornero F; Selvetella G; Brancaccio M; Vecchione C; Sbroggiò M; Collino F; Pacchioni B; Lanfranchi G; Aretini A; Ferretti R; Maffei A; Altruda F; Silengo L; Tarone G; Lembo G
Circ Res; 2005 May; 96(10):1087-94. PubMed ID: 15860758
[TBL] [Abstract][Full Text] [Related]
15. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.
Pérez López I; Cariolato L; Maric D; Gillet L; Abriel H; Diviani D
Mol Cell Biol; 2013 Aug; 33(15):2903-17. PubMed ID: 23716597
[TBL] [Abstract][Full Text] [Related]
16. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
17. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
[TBL] [Abstract][Full Text] [Related]
19. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
[TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
